ROOM-TEMPERATURE-STABLE ANTIBODIES, ANTIBIOTICS, AND VACCINES

Strategy:  Dry powders near room temperature for alveolar or nasal administration (or rapid redissolution)

Studies:

“Stabilization and Dehydration of Monoclonal Antibodies”

- Avoid aggregation and create rapidly redissolved microparticles
 

“Preparation of Stable Dry Powder Formulations of Live Attenuated Virus Vaccines for Nasal Delivery”

- Use Bubble Dryer® to process dry powders of vaccine formulations that are easier to ship, store and maintain activity.
 

“Inhalable Antibiotics”

- Micronize dry powder antibiotics for delivery to alveoli